• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿肾损伤分子-1和中性粒细胞明胶酶相关脂质运载蛋白作为2型糖尿病正常白蛋白尿患者肾小管损伤的指标

Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.

作者信息

de Carvalho José Antonio M, Tatsch Etiane, Hausen Bruna S, Bollick Yãnaí S, Moretto Maria B, Duarte Thiago, Duarte Marta M M F, Londero Sílvia W K, Premaor Melissa O, Comim Fabio V, Delanghe Joris R, Moresco Rafael N

机构信息

Laboratory of Clinical Biochemistry, Department of Clinical and Toxicological Analysis, Center of Health Sciences, Federal University of Santa Maria, Santa Maria, RS, Brazil; University Hospital, Santa Maria, RS, Brazil; Pharmaceutical Sciences Postgraduate Program, Center of Health Sciences, Federal University of Santa Maria, Santa Maria, RS, Brazil.

Laboratory of Clinical Biochemistry, Department of Clinical and Toxicological Analysis, Center of Health Sciences, Federal University of Santa Maria, Santa Maria, RS, Brazil; Pharmaceutical Sciences Postgraduate Program, Center of Health Sciences, Federal University of Santa Maria, Santa Maria, RS, Brazil.

出版信息

Clin Biochem. 2016 Feb;49(3):232-6. doi: 10.1016/j.clinbiochem.2015.10.016. Epub 2015 Oct 27.

DOI:10.1016/j.clinbiochem.2015.10.016
PMID:26519090
Abstract

OBJECTIVES

Renal dysfunction has been reported in normoalbuminuric patients, demonstrating the necessity to improve the diagnostic and prognostic tools for diabetic kidney disease (DKD) investigation. Therefore, the aim of this study was to investigate whether the urinary levels of neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) are increased in type 2 diabetes mellitus (DM) patients with normal or mildly increased albuminuria.

DESIGN AND METHODS

In this study, 117 type 2 DM patients classified into three groups according to urinary albumin/creatinine ratio (uACR): uACR<10mg/g creatinine, uACR 10-30mg/g creatinine and uACR>30mg/g creatinine were enrolled. Urinary concentrations of KIM-1 (uKIM-1) and NGAL (uNGAL) were measured.

RESULTS

uKIM-1 levels increased progressively from uACR<10mg/g creatinine (69.0±20.8pg/ml) to uACR 10-30mg/g creatinine (106.1±41.2pg/ml) and to uACR>30mg/g creatinine (166.0±31.9pg/ml) (P<0.001). In addition, uNGAL levels increased progressively from uACR<10mg/g creatinine (29.5±8.8ng/ml) to uACR 10-30mg/g creatinine (51.7±10.9ng/ml) and to uACR>30mg/g creatinine (71.0±9.6ng/ml) (P<0.001) patients. Similarly, both uKIM-1 and uNGAL adjusted by urinary creatinine were increased in patients with uACR 10-30mg/g creatinine. Significant and positive correlations were observed between uACR, uKIM-1 and uNGAL.

CONCLUSIONS

uKIM-1 and uNGAL were increased in type 2 DM patients with normal or mildly increased albuminuria, which indicates that tubular and glomerular injuries may be occurring even at the earliest stage of DKD.

摘要

目的

已有报道称正常白蛋白尿患者存在肾功能障碍,这表明有必要改进糖尿病肾病(DKD)研究的诊断和预后工具。因此,本研究的目的是调查在白蛋白尿正常或轻度升高的2型糖尿病(DM)患者中,中性粒细胞明胶酶相关脂质运载蛋白(NGAL)和肾损伤分子-1(KIM-1)的尿水平是否升高。

设计与方法

在本研究中,根据尿白蛋白/肌酐比值(uACR)将117例2型DM患者分为三组:uACR<10mg/g肌酐、uACR 10 - 30mg/g肌酐和uACR>30mg/g肌酐,并纳入研究。测量尿中KIM-1(uKIM-1)和NGAL(uNGAL)的浓度。

结果

uKIM-1水平从uACR<10mg/g肌酐(69.0±20.8pg/ml)逐渐升高至uACR 10 - 30mg/g肌酐(106.1±41.2pg/ml),再到uACR>30mg/g肌酐(166.0±31.9pg/ml)(P<0.001)。此外,uNGAL水平从uACR<10mg/g肌酐(29.5±8.8ng/ml)逐渐升高至uACR 10 - 30mg/g肌酐(51.7±10.9ng/ml),再到uACR>30mg/g肌酐(71.0±9.6ng/ml)(P<0.001)。同样,在uACR 10 - 30mg/g肌酐的患者中,经尿肌酐校正的uKIM-1和uNGAL均升高。uACR、uKIM-1和uNGAL之间存在显著正相关。

结论

在白蛋白尿正常或轻度升高的2型DM患者中,uKIM-1和uNGAL升高,这表明即使在DKD的最早阶段,肾小管和肾小球损伤可能已经发生。

相似文献

1
Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.尿肾损伤分子-1和中性粒细胞明胶酶相关脂质运载蛋白作为2型糖尿病正常白蛋白尿患者肾小管损伤的指标
Clin Biochem. 2016 Feb;49(3):232-6. doi: 10.1016/j.clinbiochem.2015.10.016. Epub 2015 Oct 27.
2
Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.2 型糖尿病患者肾脏疾病早期肾小球和肾小管损伤的标志物。
Mediators Inflamm. 2018 Aug 9;2018:7659243. doi: 10.1155/2018/7659243. eCollection 2018.
3
Is Urinary NGAL Determination Useful for Monitoring Kidney Function and Assessment of Cardiovascular Disease? A 12-Month Observation of Patients with Type 2 Diabetes.尿中性粒细胞明胶酶相关脂质运载蛋白测定对监测肾功能和评估心血管疾病是否有用?对2型糖尿病患者的12个月观察。
Dis Markers. 2016;2016:8489543. doi: 10.1155/2016/8489543. Epub 2016 Dec 5.
4
Study of Neutrophil Gelatinase Associated Lipocalin and Kidney Injury Molecule-1 in Patients with Type 2 Diabetes Mellitus Nephropathy.中性粒细胞明胶酶相关脂质运载蛋白和肾损伤分子-1 在 2 型糖尿病肾病患者中的研究。
Clin Lab. 2024 Mar 1;70(3). doi: 10.7754/Clin.Lab.2023.230824.
5
Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study.尿中性粒细胞明胶酶相关脂质运载蛋白、簇集蛋白和胱抑素C在预测糖尿病肾病和糖尿病微量白蛋白尿中的表现:一项连续队列研究。
BMC Nephrol. 2017 Jul 12;18(1):233. doi: 10.1186/s12882-017-0620-8.
6
Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.短期 2 型糖尿病患者的尿肾小管标志物:一项横断面研究。
Endocrine. 2012 Feb;41(1):82-8. doi: 10.1007/s12020-011-9509-7. Epub 2011 Jul 21.
7
Urinary Neutrophil Gelatinase-Associated Lipocalin Is Complementary to Albuminuria in Diagnosis of Early-Stage Diabetic Kidney Disease in Type 2 Diabetes.尿中性粒细胞明胶酶相关载脂蛋白在 2 型糖尿病早期糖尿病肾病诊断中与白蛋白尿互补。
Biomed Res Int. 2017;2017:4691389. doi: 10.1155/2017/4691389. Epub 2017 Aug 6.
8
Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.非白蛋白尿性蛋白尿作为 2 型糖尿病肾病早期小管损伤的生物标志物。
Diabetes Metab Res Rev. 2014 Nov;30(8):736-41. doi: 10.1002/dmrr.2546.
9
Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.组织中管状损伤标志物的表达与糖尿病肾病肾功能下降有关。
J Diabetes Complications. 2017 Dec;31(12):1704-1709. doi: 10.1016/j.jdiacomp.2017.08.009. Epub 2017 Aug 24.
10
Urinary Kidney Injury Molecule-1 but Not Urinary Neutrophil Gelatinase Associated Lipocalin Is Increased after Short Maximal Exercise.短时间最大强度运动后,尿肾损伤分子-1升高,而尿中性粒细胞明胶酶相关脂质运载蛋白未升高。
Nephron. 2018;138(1):29-34. doi: 10.1159/000481179. Epub 2017 Oct 7.

引用本文的文献

1
Obesity-related glomerulopathy: How it happens and future perspectives.肥胖相关性肾小球病:发病机制及未来展望
Diabet Med. 2025 Jun;42(6):e70042. doi: 10.1111/dme.70042. Epub 2025 Apr 14.
2
Changes in Urinary NGAL, FN, and LN Excretion in Type 2 Diabetic Patients Following Anti-Diabetic Therapy with Metformin.2型糖尿病患者接受二甲双胍抗糖尿病治疗后尿中性粒细胞明胶酶相关脂质运载蛋白、纤连蛋白和层粘连蛋白排泄量的变化
J Clin Med. 2025 Feb 8;14(4):1088. doi: 10.3390/jcm14041088.
3
Novel Insights into Diabetic Kidney Disease.糖尿病肾病的新见解。
Int J Mol Sci. 2024 Sep 23;25(18):10222. doi: 10.3390/ijms251810222.
4
Novel Biomarkers for the diagnosis of diabetic nephropathy.用于诊断糖尿病肾病的新型生物标志物。
Caspian J Intern Med. 2024 Summer;15(3):382-391. doi: 10.22088/cjim.15.3.382.
5
Identification of immune-associated biomarkers of diabetes nephropathy tubulointerstitial injury based on machine learning: a bioinformatics multi-chip integrated analysis.基于机器学习的糖尿病肾病肾小管间质损伤免疫相关生物标志物的鉴定:一项生物信息学多芯片综合分析
BioData Min. 2024 Jul 1;17(1):20. doi: 10.1186/s13040-024-00369-x.
6
Phloretamide Protects against Diabetic Kidney Damage and Dysfunction in Diabetic Rats by Attenuating Hyperglycemia and Hyperlipidemia, Suppressing NF-κβ, and Upregulating Nrf2.根皮酰胺通过减轻高血糖和高血脂、抑制核因子κB(NF-κβ)以及上调核因子E2相关因子2(Nrf2)来保护糖尿病大鼠免受糖尿病肾病损伤和功能障碍。
Pharmaceutics. 2024 Apr 7;16(4):505. doi: 10.3390/pharmaceutics16040505.
7
Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus.恩格列净和帕立骨化醇联合治疗 2 型糖尿病小鼠的血糖控制改善和肾脏保护作用。
Int J Mol Sci. 2023 Dec 12;24(24):17380. doi: 10.3390/ijms242417380.
8
Pathomechanisms of Diabetic Kidney Disease.糖尿病肾病的发病机制
J Clin Med. 2023 Nov 27;12(23):7349. doi: 10.3390/jcm12237349.
9
Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms.理解和治疗糖尿病肾病的进展:聚焦于肾小管间质性炎症机制。
Front Endocrinol (Lausanne). 2023 Oct 4;14:1232790. doi: 10.3389/fendo.2023.1232790. eCollection 2023.
10
Novel Biomarkers of Diabetic Kidney Disease.糖尿病肾病的新型生物标志物。
Biomolecules. 2023 Mar 31;13(4):633. doi: 10.3390/biom13040633.